← Latest papers
📄 cell biology

N-terminal truncation diversifies USP18 function during early myogenesis

This study reveals that the N-terminally truncated short isoform of USP18, distinct from its canonical long form in stability and localization, acts as a novel regulator of early myogenesis by expanding protein interactions and modulating alternative splicing of key sarcomere genes.

Original authors: Raz, V., Nijssen, T., Draganov, S., Shademan, M., Vendrell, I., Kessler, B. M., Pinto-Fernandez, A., flannery, S.

Published 2026-10-18
📖 6 min read🧠 Deep dive

Original authors: Raz, V., Nijssen, T., Draganov, S., Shademan, M., Vendrell, I., Kessler, B. M., Pinto-Fernandez, A., flannery, S.

Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). ⚕️ This is an AI-generated explanation of a preprint that has not been peer-reviewed. It is not medical advice. Do not make health decisions based on this content. Read full disclaimer

Inside every cell, there is a complex system for managing proteins, the tiny machines that carry out the work of life. Among these managers is a protein called USP18. For years, scientists have known USP18 as a key regulator of the immune system, specifically helping cells decide how to respond to viral threats. It acts like a switch, turning off signals that tell the cell to fight infection once the danger has passed. However, recent observations suggested that USP18 does something else entirely when it is inside muscle cells, even when no virus is present. It appears to play a role in how muscle cells grow and mature, a process known as myogenesis. This raised a puzzling question: how can the same protein do two such different jobs? The answer lies in the fact that USP18 is not just one single shape. It exists in two slightly different forms, or isoforms, created by starting the protein's construction at different points. One form is long, and the other is short because it is missing the first 35 building blocks at its beginning. While the long form is known to stay mostly in the fluid part of the cell, the short form was found to accumulate in the nucleus, the command center where genetic instructions are read. But what the short form actually does in that command center remained a mystery.

A team of researchers set out to solve this mystery by comparing these two forms of USP18 directly inside human muscle cells. They created special cell lines where they could turn on either the long version or the short version of the protein and watch what happened. They found that the two forms behave very differently. The long version stayed mostly in the cell's fluid, while the short version moved into the nucleus. This difference in location was not just a matter of geography; it changed how stable the proteins were. The short form lasted longer inside the cell, resisting the natural breakdown that usually clears out proteins. More importantly, the two forms interacted with completely different groups of other proteins. The long form had a relatively small list of partners, but the short form, once inside the nucleus, grabbed onto a much larger and more diverse group of proteins. Many of these partners were involved in keeping the cell's internal environment stable, fixing damaged proteins, and managing how genetic instructions are read and edited.

The researchers then watched how these cells developed into muscle fibers. They discovered that the short form of USP18 acted as a catalyst for early muscle development. Cells with the short form began to fuse together and express markers of muscle maturity much faster than cells with the long form or cells with no extra USP18 at all. In contrast, the long form seemed to slow down cell growth, keeping the cells in a state of waiting rather than moving forward. This suggested that the short form is the active driver of muscle formation, while the long form might serve a different, perhaps regulatory, purpose. To understand how the short form achieved this, the team looked at the genetic instructions inside the nucleus. They found that the presence of the short form changed how the cell processed its genetic code. Specifically, it altered a process called alternative splicing, which is how cells decide which parts of a genetic message to keep and which to discard when building a protein. This change affected several genes critical for muscle structure, including those that build the scaffolding of the muscle fiber.

The study revealed that the short form of USP18 binds to specific proteins that help edit genetic messages, such as a factor called SF3B2. By interacting with these editing tools, the short form appears to fine-tune the production of muscle proteins, ensuring they are built correctly during the early stages of development. The researchers also noted that the short form's ability to stay in the nucleus and interact with these partners was linked to its missing starting segment. Without those first 35 building blocks, the protein changed its shape just enough to stay in the nucleus and grab onto a new set of partners, effectively giving it a new job description. This finding suggests that the body uses these subtle variations in protein structure to create distinct functions from a single gene. The short form is not just a broken version of the long one; it is a specialized tool evolved to manage the complex task of turning a simple muscle cell into a mature, working muscle fiber.

The work also clarified what USP18 is not doing in this context. The changes observed were not driven by the immune system's response to viruses, nor were they caused by the protein's ability to remove a specific tag called ISG15 from other proteins. The effects happened independently of those known immune functions. Instead, the research points to a non-canonical role for USP18, where it acts as a structural scaffold, organizing other proteins to manage the cell's internal stability and genetic editing. The researchers found that the short form interacts with proteins involved in stress response and protein quality control, suggesting it helps the cell maintain order while it undergoes the rapid changes of muscle growth. They observed that cells with the short form showed signs of increased protein recycling activity, indicated by the presence of specific markers that appear when the cell is managing its internal inventory. This supports the idea that the short form helps the cell reorganize its machinery to support the demanding task of building new muscle tissue.

Ultimately, this study provides a clear picture of how a single protein can diversify its function through simple structural changes. The long form of USP18 remains in the cytoplasm, likely managing immune signals, while the short form moves to the nucleus to orchestrate the early steps of muscle development. By altering the starting point of the protein, the cell creates a version that is more stable, has a different set of partners, and performs a completely different task. The researchers suggest that this mechanism allows the body to use the same genetic blueprint for multiple purposes, ensuring that muscle cells can grow and mature efficiently without interference from the immune system's usual pathways. The findings highlight the importance of looking beyond the main, well-known functions of proteins to understand the subtle variations that drive complex biological processes like muscle regeneration.

Drowning in papers in your field?

Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.

Try Digest →